Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lipid abnormalities in uremia, dialysis, and transplantation.

× No keyword cloud information.

25 in total

1. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.

Authors: S Türk; A Yildiz; T Tükek; V Akkaya; U Aras; A Türkmen; A R Uras; M S Sever
Journal: Int Urol Nephrol Date: 2001 Impact factor: 2.370

2. Unusual pattern of dyslipidemia in children receiving steroid minimization immunosuppression after renal transplantation.

Authors: Keith K Lau; Daniel J Tancredi; Richard V Perez; Lavjay Butani
Journal: Clin J Am Soc Nephrol Date: 2010-05-27 Impact factor: 8.237

3. Potential role of carnitine in patients with renal insufficiency.

Authors: C Wanner; W H Hörl
Journal: Klin Wochenschr Date: 1986-07-01

4. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.

Authors: O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal: Transplant Proc Date: 1993-08 Impact factor: 1.066

5. What is the role of lipoprotein abnormalities and platelet aggregation defects in cardiovascular disease in chronic dialysis patients?

Authors: J Winkler; G Boner; D Gavish; J Fuchs; I Weinberger
Journal: Int Urol Nephrol Date: 1997 Impact factor: 2.370

Lipid abnormalities in uremia, dialysis, and transplantation.

1. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.

2. Unusual pattern of dyslipidemia in children receiving steroid minimization immunosuppression after renal transplantation.

3. Potential role of carnitine in patients with renal insufficiency.

4. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.

5. What is the role of lipoprotein abnormalities and platelet aggregation defects in cardiovascular disease in chronic dialysis patients?

6. Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders.

Review 7. Causes of dysregulation of lipid metabolism in chronic renal failure.

8. Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.

9. Paraoxonase: Its antiatherogenic role in chronic renal failure.

Review 10. Derangement of glucose metabolism in hyperparathyroidism.